Condition
Hypermobile EDS (hEDS)
Total Trials
6
Recruiting
0
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed2
Unknown2
Active Not Recruiting1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07464093Not ApplicableNot Yet Recruiting
STABLE Pilates for Hypermobility
NCT06548594Not ApplicableActive Not RecruitingPrimary
Out of State - tAN hEDS
NCT04972565Not ApplicableCompletedPrimary
Dyspnea in Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorder
NCT05429996Unknown
Ultrastructural Collagen Markers in Ehlers Danlos Syndromes
NCT05434728Unknown
Characterization of Bleeding Disorders in EDS
NCT04734041Not ApplicableCompleted
Integrative Medicine for Hypermobility Spectrum Disorder and Ehlers-Danlos Syndromes (IMforHSDandEDS)
Showing all 6 trials